Late local treatment morbidity after accelerated radiotherapy or alternating chemoradiotherapy for advanced head and neck carcinoma

Tumori

Volumn 88, Issue 4, 2002, Pages 313-320

  Sanguineti, Giuseppe ^a   Sormani, Maria Pia ^a   Benasso, Marco ^a   Corvò, Renzo ^a   Foppiano, Franca ^a   Ricci, Isabella ^a   Marcenaro, Michela ^a   Rosso, Riccardo ^a   Vitale, Vito ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Chemotherapy; Head and neck carcinoma; Late toxicity; Radiotherapy

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; DISEASE SEVERITY; HEAD AND NECK CARCINOMA; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MUCOSA INFLAMMATION; RADIATION DOSE; RADIATION INJURY; RISK FACTOR;

EID: 0036658210     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160208800413     Document Type: Article

References (41)

1. Pignon JP, Bourhis J, Domenge C, Designe L: Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet, 355: 949-955, 2000.
2. Merlano M, Vitale V, Rosso R, Benasso M, Corvo R, Cavallari M, Sanguineti G, Bacigalupo A, Badellino F, Margarino G: Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N Engl J Med, 327: 1115-1121, 1992.
3. Munro AJ: An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer, 71: 83-91, 1995.
4. El-Sayed S, Nelson N: Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials. J Clin Oncol, 14: 838-847, 1996.
5. Brizel DM, Albers ME, Fisher SR, Scher RL, Richtsmeier WJ, Hars V, George SL, Huang AT, Prosnitz LR: Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med, 338: 1798-1804, 1998.
6. Leyvraz S, Pasche P, Bauer J, Bernasconi S, Monnier P: Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma: four-year results of a phase I/II study. J Clin Oncol, 12: 1876-1885, 1994.
7. Adelstein DJ, Kalish LA, Adams GL, Wagner H Jr, Oken MM, Remick SC, Mansour EG, Haselow RE: Concurrent radiation therapy and chemotherapy for locally unresectable squamous cell head and neck cancer: an Eastern Cooperative Oncology Group pilot study. J Clin Oncol, 11: 2136-2142, 1993.
8. Taylor SG 4th, Murthy AK, Caldarelli DD, Showel JL, Kiel K, Griem KL, Mittal BB, Kies M, Hutchinson JC Jr, Holinger LD: Combined simultaneous cisplatin/fluorouracil chemotherapy and split course radiation in head and neck cancer. J Clin Oncol, 7: 846-856, 1989.
9. Brockstein B, Haraf DJ, Stenson K, Fasanmade A, Stupp R, Glisson B, Lippman SM, Ratain MJ, Sulzen L, Klepsch A, Weichselbaum RR, Vokes EE: Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neck. J Clin Oncol, 16: 735-744, 1998.
10. Wibault P, Bensmaine MA, De Forni M, Armand JP, Tellez Bernal E, Guillot T, Recondo G, Domenge C, Janot F, Borel C, Luboinski B, Eschwege F, Cvitkovic E: Intensive concomitant chemoradiotherapy in locally advanced unresectable squamous cell carcinoma of the head and neck: a phase II study of radiotherapy with cisplatin and 7-week continuous infusional fluorouracil. J Clin Oncol, 14: 1192-1200, 1996.
11. Vokes EE, Haraf DJ, Mick R, McEvilly JM, Weichselbaum RR: Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer. J Clin Oncol, 12: 2351-2359, 1994.
12. Peters LJ, Harrison ML, Dimery IW, Fields R, Goepfert H, Oswald MJ: Acute and late toxicity associated with sequential bleomycin-containing chemotherapy regimens and radiation therapy in the treatment of carcinoma of the nasopharynx. Int J Radiat Oncol Biol Phys, 14: 623-633, 1988.
13. Trotti A: Toxicity in head and neck cancer: a review of trends and issues. Int J Radiat Oncol Biol Phys, 47: 1-12, 2000.
14. Tupchong L, Scott CB, Blitzer PH, Marcial VA, Lowry LD, Jacobs JR, Stetz J, Davis LW, Snow JB, Chandler R: Randomized study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma: long-term follow-up of RTOG study 73-03. Int J Radiat Oncol Biol Phys, 20: 21-28, 1991.
15. Horiot JC, Bontemps P, Van den Bogaert W, Le Fur R, Van den Weijngaert D, Bolla M, Bernier J, Lusinchi A, Stuschke M, Lopez-Torrecilla J, Begg AC, Pierart M, Collette L: Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiother Oncol, 44: 111-121, 1997.
16. Fu KK, Pajak TF, Trotti A, Jones CU, Spencer SA, Phillips TL, Garden AS, Ridge JA, Cooper JS, Ang KK: A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys, 48: 7-16, 2000.
17. Corvò R, Sanguineti G, Scala M, Garaventa G, Santelli A, Barbieri M, Vitale V: Primary site as predictive factor of local control in advanced head and neck tumors treated by concomitant boost accelerated radiotherapy. Tumori, 80: 135-138, 1994.
18. Corvò R, Benasso M, Sanguineti G, Ricci I, Merlano M, Rosso R, Vitale V: Alternating chemoradiotherapy versus partly accelerated radiotherapy: results from a phase III study. Cancer, 92: 2856-2867, 2001.
19. Ang KK, Kaander JHAM, Peters LJ: Radiotherapy for head and neck cancers. Lea & Febiger, Philadelphia, 1994.
20. Knee R, Fields RS, Peters LJ: Concomitant boost radiotherapy for advanced squamous cell carcinoma of the head and neck. Radiother Oncol 4: 1-7, 1985.
21. Cox JD, Stetz J, Pajak TF: Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer. Int J Radiat Oncol Biol Phys, 131: 1341-1346, 1995.
22. Fu KK, Pajak TF, Marcial VA, Ortiz HG, Rotman M, Asbell SO, Coia LR, Vora NL, Byhardt R, Rubin P: Late effects of hyperfractionated radiotherapy for advanced head and neck cancer: long-term follow-up results of RTOG 83-13. Int J Radiat Oncol Biol Phys, 32: 577-588, 1995
23. Withers HR, Peters LJ, Taylor JM, Owen JB, Morrison WH, Schultheiss TE, Keane T, O'Sullivan B, Van Dyk J, Gupta N: Late normal tissue sequelae from radiation therapy for carcinoma of the tonsil: patterns of fractionation study of radiobiology. Int J Radiat Oncol Biol Phys, 33: 563-568, 1995.
24. Lee DJ, Cosmatos D, Marcial VA, Fu KK, Rotman M, Cooper JS, Ortiz HG, Beitler JJ, Abrams RA, Curran WJ: Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas. Int J Radiat Oncol Biol Phys, 32: 567-576, 1995.
25. Dische S, Saunders M, Barrett A, Harvey A, Gibson D, Parmar M: A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol, 44: 123-136, 1997.
26. Overgaard J, Hjelm-Hansen M, Johansen LV, Andersen AP: Comparison of conventional and split-course radiotherapy as primary treatment in carcinoma of the larynx. Acta Oncol, 27: 147-152, 1988.
27. Caplan RJ, Pajak TF, Cox JD: Analysis of the probability and risk of cause-specific failure. Int J Radiat Oncol Biol Phys, 29: 1183-1186, 1994.
28. Bentzen SM, Vaeth M, Pedersen DE, Overgaard J: Why actuarial estimates should be used in reporting late normal-tissue effects of cancer treatment ... now! Int J Radiat Oncol Biol Phys, 32: 1531-1534, 1995.
29. Bentzen SM, Overgaard M, Overgaard J: Clinical correlations between late normal tissue endpoints after radiotherapy: implications for predictive assays of radiosensitivity. Eur J Cancer, 29A: 1373-1376, 1993.
30. List MA, Siston A, Haraf D, Schumm P, Kies M, Stenson K, Vokes EE: Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: a prospective examination. J Clin Oncol, 17: 1020-1028, 1999.
31. Haie-Meder C, Kramar A, Lambin P, Lancar R, Scalliet P, Bouzy J, Gerbaulet A: Analysis of complications in a prospective randomized trial comparing two brachytherapy low dose rates in cervical carcinoma. Int J Radiat Oncol Biol Phys, 29: 953-960, 1994.
32. Peters LJ, Ang KK, Thames HD Jr: Accelerated fractionation in the radiation treatment of head and neck cancer. A critical comparison of different strategies. Acta Oncol, 27: 185-194, 1988.
33. Kaanders JH, Van Daal WA, Hoogenraad WJ, Van der Kogel AJ: Accelerated fractionation radiotherapy for laryngeal cancer, acute, and late toxicity. Int J Radiat Oncol Biol Phys, 24: 497-503, 1992.
34. Bourhis J, Fortin A, Dupuis O, Domenge C, Lusinchi A, Marandas P, Schwaab G, Armand JP, Luboinski B, Malaise E: Very accelerated radiation therapy: preliminary results in locally unresectable head and neck carcinomas. Int J Radiat Oncol Biol Phys, 32: 747-752, 1995.
35. Olmi P, Cellai E, Chiavacci A, Fallai C: Accelerated fractionation in advanced head and neck cancer: results and analysis of late sequelae. Radiother Oncol, 17: 199-207, 1990.
36. Nguyen TD, Panis X, Froissart D, Legros M, Coninx P, Loirette M: Analysis of late complications after rapid hyperfractionated radiotherapy in advanced head and neck cancers. Int J Radiat Oncol Biol Phys, 14: 23-25, 1988.
37. Jackson SM, Weir LM, Hay JH, Tsang VH, Durham JS: A randomised trial of accelerated versus conventional radiotherapy in head and neck cancer. Radiother Oncol, 43: 39-46, 1997.
38. Wendt TG, Grabenbauer GG, Rodel CM, Thiel HJ, Aydin H, Rohloff R, Wustrow TP, Iro H, Popella C, Schalhorn A: Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J Clin Oncol 16: 1318-1324, 1998.
39. Calais G, Alfonsi M, Bardet E, Sire C, Germain T, Bergerot P, Rhein B, Tortochaux J, Oudinot P, Bertrand P: Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst, 91: 2081-2086, 1999.
40. Merlano M, Benasso M, Corvo R, Rosso R, Vitale V, Blengio F, Numico G, Margarino G, Bonelli L, Santi L: Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. J Natl Cancer Inst, 88: 583-589, 1996.
41. Denis F, Alfonsi M, Bardet E, Sire C, Germain T, Bergerot P, Rhein B, Tortochaux J, Garaud P, Calais G: Late toxicity results of randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma (GORTEC 94-01). Int J Radiat Oncol Biol Phys, 51: 39, 2001.